Dolor Technologies


SphenoCath is a company dedicated to providing a superior intra-nasal solution for targeted delivery of injectate to the SphenoPalatine Foramen (SPF). Their innovative device simplifies the procedure, making it quick, effective, and accessible worldwide. They focus on educating providers and the public about the benefits of their device, which offers precise, needle-free treatment options for nasal conditions.

Industries

biotechnology
consulting
delivery
medical
medical-device
professional-services

Nr. of Employees

small (1-50)

Dolor Technologies

South Jordan, Utah, United States, North America


Products

Disposable intra-nasal applicator for targeted delivery to the sphenopalatine foramen

A single-use intra-nasal applicator engineered to reach above the middle turbinate and deliver small volumes of injectate directly to the sphenopalatine foramen for rapid topical anesthetic or therapeutic effect.


Services

Clinical webinars and provider education

Scheduled online webinars that demonstrate procedure technique, device use, and clinical considerations for licensed providers.

Provider onboarding and practice integration support

Consultation and contact-based support for clinicians interested in adding the procedure to their practice, including access to trained provider network information.

Expertise Areas

  • Targeted intra-nasal drug delivery
  • Minimally invasive ENT device design
  • Needle-free topical anesthetic administration
  • Outpatient procedural workflow development
  • Show More (3)

Key Technologies

  • Anatomical-targeted nasal applicator design
  • Needle-free topical drug delivery
  • Single-use disposable applicator design
  • Localized delivery to sphenopalatine foramen
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.